Amir Pesyan

Person

Salt Lake City, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds advantageous in the treatment of central nervous system d...
- Patent number 10,793,515
- Issue date Oct 6, 2020
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds advantageous in the treatment of central nervous system d...
- Patent number 9,212,155
- Issue date Dec 15, 2015
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds advantageous in the treatment of central nervous system d...
- Patent number 9,206,143
- Issue date Dec 8, 2015
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods to manufacture 1,3-dioxolane nucleosides
- Patent number 8,420,354
- Issue date Apr 16, 2013
- Emory University
- Marcos Sznaidman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods to manufacture 1,3-dioxolane nucleosides
- Patent number 7,785,839
- Issue date Aug 31, 2010
- Emory University
- Marcos Sznaidman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM D...
- Publication number 20240239739
- Publication date Jul 18, 2024
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...
- Publication number 20210130285
- Publication date May 6, 2021
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...
- Publication number 20160137592
- Publication date May 19, 2016
- AURIMMED PHARMA, INC.
- Amir Pesyan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods to Manufacture 1,3-Dioxolane Nucleosides
- Publication number 20110130559
- Publication date Jun 2, 2011
- GILEAD SCIENCES, INC.
- Marcos Sznaidman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...
- Publication number 20110046138
- Publication date Feb 24, 2011
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...
- Publication number 20110046128
- Publication date Feb 24, 2011
- AURIMMED PHARMA, INC.
- Amir Pesyan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods to manufacture 1,3-dioxolane nucleosides
- Publication number 20060036092
- Publication date Feb 16, 2006
- Marcos Sznaidman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Analogs of isovaleramide, a pharmaceutical composition including th...
- Publication number 20060025477
- Publication date Feb 2, 2006
- Linda D. Artman
- C07 - ORGANIC CHEMISTRY

Amir Pesyan

Person

Patents Grantslast 30 patents

Compounds advantageous in the treatment of central nervous system d...

Compounds advantageous in the treatment of central nervous system d...

Compounds advantageous in the treatment of central nervous system d...

Methods to manufacture 1,3-dioxolane nucleosides

Methods to manufacture 1,3-dioxolane nucleosides

Patents Applicationslast 30 patents

COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM D...

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...

Methods to Manufacture 1,3-Dioxolane Nucleosides

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SY...

Methods to manufacture 1,3-dioxolane nucleosides

Analogs of isovaleramide, a pharmaceutical composition including th...